Empfehlungen für den Einsatz von Rituximab (anti-CD20-Antikörper) bei bullösen Autoimmundermatosen § Recommendations for the use of rituximab (anti-CD20 antibody) in the treatment of autoimmune bullous skin diseases

mag(2008)

Cited 23|Views12
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined